plerixafor has been researched along with Bronchial Hyperreactivity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, A; Bridger, GJ; Lukacs, NW; Schols, D; Skerlj, RT | 1 |
1 other study(ies) available for plerixafor and Bronchial Hyperreactivity
| Article | Year |
|---|---|
AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.
Topics: Allergens; Animals; Benzylamines; Bronchial Hyperreactivity; Cell Movement; Chemokines; Cyclams; Cytokines; Female; Heterocyclic Compounds; Hypersensitivity; Leukocytes; Mice; Mice, Inbred CBA; Pneumonia; Receptors, CXCR4 | 2002 |